179 related articles for article (PubMed ID: 16972974)
21. Pragmatic management of hyperglycaemia in acute ischaemic stroke: safety and feasibility of intensive intravenous insulin treatment.
Kreisel SH; Berschin UM; Hammes HP; Leweling H; Bertsch T; Hennerici MG; Schwarz S
Cerebrovasc Dis; 2009; 27(2):167-75. PubMed ID: 19092238
[TBL] [Abstract][Full Text] [Related]
22. [Educational value of diabetes camps for children].
Métroz-Dayer MD; Roulet E
Schweiz Med Wochenschr; 1990 Jan; 120(3):66-71. PubMed ID: 2300792
[TBL] [Abstract][Full Text] [Related]
23. [24-hours monitoring of ECG and glucose level for detection of relations between glycemia and QT interval duration in patients with type 1 diabetes].
Laptev DN; Riabykina GV; Seid-Guseĭnov AA
Ter Arkh; 2009; 81(4):28-33. PubMed ID: 19514418
[TBL] [Abstract][Full Text] [Related]
24. A protocolized approach to identify and manage hyperglycemia in a pediatric critical care unit.
Preissig CM; Hansen I; Roerig PL; Rigby MR
Pediatr Crit Care Med; 2008 Nov; 9(6):581-8. PubMed ID: 18838924
[TBL] [Abstract][Full Text] [Related]
25. Evaluation in clinical practice of Dextrostix and the Eyetone Reflectance Meter.
West TE; Judd SL; Sönksen PH
Diabete Metab; 1977 Sep; 3(3):165-7. PubMed ID: 913748
[TBL] [Abstract][Full Text] [Related]
26. Current status of diabetes management in elderly Koreans with diabetes.
Noh JH; Kim SK; Cho YJ; Nam HU; Kim IJ; Jeong IK; Choi MG; Yoo HJ; Ahn YH; Bae HY; Jang HC
Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S71-5. PubMed ID: 17481770
[TBL] [Abstract][Full Text] [Related]
27. Hypoglycemia rates in the first days of life among term infants born to diabetic mothers.
Maayan-Metzger A; Lubin D; Kuint J
Neonatology; 2009; 96(2):80-5. PubMed ID: 19225239
[TBL] [Abstract][Full Text] [Related]
28. Injury patterns at US and Canadian overnight summer camps: first year of the Healthy Camp study.
Goldlust E; Walton E; Stanley R; Yard E; Garst B; Comstock RD; Erceg LE; Cunningham R
Inj Prev; 2009 Dec; 15(6):413-7. PubMed ID: 19959735
[TBL] [Abstract][Full Text] [Related]
29. Prevailing therapeutic regimes and predictive factors for prandial insulin substitution in 26 687 children and adolescents with Type 1 diabetes in Germany and Austria.
Knerr I; Hofer SE; Holterhus PM; Näke A; Rosenbauer J; Weitzel D; Wolf J; Holl RW
Diabet Med; 2007 Dec; 24(12):1478-81. PubMed ID: 17971184
[TBL] [Abstract][Full Text] [Related]
30. Immediate in-patient management of hyperglycaemia--confusion rather than consensus?
Penfold S; Gouni R; Hamilton P; Richardson T; Kerr D
QJM; 2008 Feb; 101(2):87-90. PubMed ID: 18180257
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of inhaled insulin (AERx iDMS) compared with subcutaneous insulin therapy in patients with Type 1 diabetes: 1-year data from a randomized, parallel group trial.
Moses RG; Bartley P; Lunt H; O'Brien RC; Donnelly T; Gall MA; Vesterager A; Wollmer P; Roberts A
Diabet Med; 2009 Mar; 26(3):260-7. PubMed ID: 19317821
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials.
Bazzano LA; Lee LJ; Shi L; Reynolds K; Jackson JA; Fonseca V
Diabet Med; 2008 Aug; 25(8):924-32. PubMed ID: 18959605
[TBL] [Abstract][Full Text] [Related]
33. Management of diabetes at summer camps.
Ciambra R; Locatelli C; Suprani T; Pocecco M
Acta Biomed; 2005; 76 Suppl 3():81-4. PubMed ID: 16915805
[TBL] [Abstract][Full Text] [Related]
34. Insulin glargine improves glycaemic control after coronary surgery in patients with diabetes or pre-diabetes.
Hagelberg A; Ivert T; Efendić S; Ohrvik J; Anderson RE
Scand Cardiovasc J; 2008 Feb; 42(1):71-6. PubMed ID: 18273733
[TBL] [Abstract][Full Text] [Related]
35. Dosing of insulin glargine in the treatment of type 2 diabetes.
Barnett A
Clin Ther; 2007 Jun; 29(6):987-99. PubMed ID: 17692716
[TBL] [Abstract][Full Text] [Related]
36. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Barzilay JI; Davis BR; Cutler JA; Pressel SL; Whelton PK; Basile J; Margolis KL; Ong ST; Sadler LS; Summerson J;
Arch Intern Med; 2006 Nov; 166(20):2191-201. PubMed ID: 17101936
[TBL] [Abstract][Full Text] [Related]
37. Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes.
Klein O; Lynge J; Endahl L; Damholt B; Nosek L; Heise T
Diabetes Obes Metab; 2007 May; 9(3):290-9. PubMed ID: 17391154
[TBL] [Abstract][Full Text] [Related]
38. Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes.
Robertson KJ; Schoenle E; Gucev Z; Mordhorst L; Gall MA; Ludvigsson J
Diabet Med; 2007 Jan; 24(1):27-34. PubMed ID: 17227321
[TBL] [Abstract][Full Text] [Related]
39. Blood glucose concentration and outcome of critical illness: the impact of diabetes.
Egi M; Bellomo R; Stachowski E; French CJ; Hart GK; Hegarty C; Bailey M
Crit Care Med; 2008 Aug; 36(8):2249-55. PubMed ID: 18664780
[TBL] [Abstract][Full Text] [Related]
40. Improved glycemic control among Thai children and young adults with type 1 diabetes participating in the diabetes camp.
Santiprabhob J; Likitmaskul S; Sriwijitkamol A; Peerapatdit T; Sawathiparnich P; Nitiyanant W; Angsusingha K; Tuchinda C; Tandhanand S
J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S38-43. PubMed ID: 16856424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
